The funding, which is to be spread over a five-year period, will mean we can continue our groundbreaking ‘translational research’ turning innovations in basic science into treatments and therapies that have a direct effect on patients .
An award of £98,204,505 from the National Institute for Health Research (NIHR), which was announced this week, was made to the NIHR UCLH/UCL Comprehensive Biomedical Research Centre (BRC) on the basis of the partnership’s world-class translational research and research facilities. A further £4.5 million was awarded to enable UCLH and UCL to set up a biomedical research unit specialising in dementia.
The BRC invests in staff posts, equipment, facilities and training, to enable researchers to translate fundamental biomedical research into clinical research that benefits patients. The BRC has become a world leader in areas such as cancer, cardiovascular disease and the neurosciences.
Examples of BRC-funded research include research into gene therapy for blood cancers and diseases such as haemophilia B, identification of genetic causes of cancer and methods of prevention of MRSA.
Director of the BRC Professor Deenan Pillay
Director of the BRC Professor Deenan Pillay said: "I can’t express how pleased we are here at the BRC. It means we can continue our plans to develop some of the most cutting-edge experimental medicine. The BRC is a powerful partnership between leading clinicians and scientists, and we want to build on our partnership working. This will bring the optimal cutting edge, research led care to patients."
Sir Robert Naylor, UCLH chief executive, said: “I am delighted that the excellence of biomedical research at UCLH has been recognised again by this national award. It will allow us to work at the leading edge of translating scientific discovery into routine patient treatments. Congratulations to all of our research and clinical staff involved in this great achievement."
Key to the success has been the close geographical proximity between UCLH and UCL.
The UCLH and UCL Comprehensive Biomedical Research Centre succeeded in the original award in 2007. Since then the Centre has invested in hundreds of different research projects. This government funding from the BRC has attracted more than £90 million from external sources such as drug companies and charities who wish to undertake research in collaboration with us.